Top Biotechnology & Medical Research stocks in United States
Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.
Name | Market Cap | Price to Earnings TTM | Dividend Yield % TTM |
---|---|---|---|
REGNRegeneron Pharmaceuticals | $105.86bn | 26.49 | n/a |
VRTXVertex Pharmaceuticals | $105.31bn | 29.34 | n/a |
IQVIqvia Holdings | $45.87bn | 32.65 | n/a |
SGENSeagen | $43.15bn | n/a | n/a |
MRNAModerna | $39.68bn | n/a | n/a |
ICLRIcon | $27.62bn | 39.55 | n/a |
BNTXBioNTech SE | $21.98bn | 7.56 | n/a |
ALNYAlnylam Pharmaceuticals | $18.80bn | n/a | n/a |
NBIXNeurocrine Biosciences | $13.84bn | 39.25 | n/a |
CRLCharles River Laboratories International | $13.30bn | 32.71 | n/a |
KRTXKaruna Therapeutics | $12.58bn | n/a | n/a |
MEDPMedpace Holdings | $12.20bn | 44.7 | n/a |
SRPTSarepta Therapeutics | $11.55bn | n/a | n/a |
TECHBIO-TECHNE | $11.40bn | 50.37 | 0.44% |
UTHRUnited Therapeutics | $11.10bn | 11.87 | n/a |
LEGNLegend Biotech | $10.57bn | n/a | n/a |
EXASExact Sciences | $10.48bn | n/a | n/a |
QGENQiagen NV | $9.75bn | 26.44 | n/a |
RXDXPrometheus Biosciences | $9.56bn | n/a | n/a |
IMGNImmunoGen | $8.72bn | n/a | n/a |